Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-22

FDA Approved: ALISKIREN — Original Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved Endo USA, Inc.'s original ANDA for aliskiren, a generic renin inhibitor used to treat hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aliskiren (Aliskiren)

Snippet

ORIG AP for ALISKIREN (ALISKIREN)